This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 5 EPO patents. Top assignee: Bioceuticals Arzneimittel Ag. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2010
Title: Christof Schumann: Innovator in Erythropoietin Formulations
Introduction
Christof Schumann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of erythropoietin formulations. With a total of 2 patents, Schumann's work focuses on enhancing the stability and purity of erythropoietin, a critical protein used in treating anemia.
Latest Patents
Schumann's latest patents include innovative methods and formulations that improve the efficacy of erythropoietin. The first patent, titled "Erythropoietin Liquid Formulation," describes stable liquid formulations that do not require preservatives, urea, or human serum albumin. This formulation includes a combination of amino acids such as leucine, isoleucine, threonine, glutamic acid, aspartic acid, and phenylalanine.
The second patent, "Method for Purifying Erythropoietin," outlines a sophisticated method for producing recombined erythropoietin with a purity level of at least 98%. This method involves a series of five chromatographic purification steps, ensuring a high-quality end product. The steps include anion exchange chromatography, hydrophobic interaction chromatography, affinity chromatography, and hydroxyapatite chromatography, arranged in a specific order to maximize purity.
Career Highlights
Throughout his career, Schumann has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Bioceuticals Arzneimittel AG and Stada Arzneimittel AG. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.
Collaborations
Schumann has collaborated with several professionals in his field, including Jan-Ole Hesse and Michael Mack. These collaborations have likely enriched his research and development efforts, leading to his successful patent applications.
Conclusion
Christof Schumann's contributions to erythropoietin formulations and purification methods highlight his innovative spirit and dedication to improving biopharmaceuticals. His patents reflect a commitment to advancing medical treatments and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile